{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:51Z","timestamp":1786991151155,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaad.2022.10.015","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T23:19:57Z","timestamp":1665789597000},"page":"380-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study"],"prefix":"10.1016","volume":"88","author":[{"given":"Pauline","family":"Voland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahim","family":"Azzouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Raison-Peyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Du-Thanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Staumont-Sall\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jachiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Nosbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Valois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Leleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Lebrun-Vignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Trenque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Hettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuelle","family":"Viguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaad.2022.10.015_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.015_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2340\/00015555-0249","article-title":"Intravenous immunoglobulin: properties, mode of action and practical use in dermatology","volume":"87","author":"Prins","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2022.10.015_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","article-title":"Safety of intravenous immunoglobulin (IVIG) therapy","volume":"6","author":"Katz","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2022.10.015_bib4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.015_bib5","first-page":"194","article-title":"Aseptic meningitis induced by intravenous immunoglobulins in a child with acute Epstein-Barr virus infection and thrombocytopenia","volume":"27","author":"Vassalini","year":"2019","journal-title":"Infez Med"},{"issue":"7069","key":"10.1016\/j.jaad.2022.10.015_bib6","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/bmj.313.7069.1399c","article-title":"Intravenous immunoglobulin in the Guillain-Barr\u00e9 syndrome. May cause severe adverse skin reactions","volume":"313","author":"Hamdalla","year":"1996","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jaad.2022.10.015_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejim.2008.04.022","article-title":"Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study","volume":"20","author":"Cohen Aubart","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.015_bib8","first-page":"337","article-title":"Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy","volume":"2","author":"Uyttendaele","year":"2003","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.10.015_bib9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.53.5.1154","article-title":"Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease","volume":"53","author":"Iannaccone","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.015_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaad.2010.12.034","article-title":"Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy","volume":"66","author":"Gerstenblith","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.015_bib11","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/j.1525-1470.2011.01717.x","article-title":"Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome","volume":"30","author":"Shiraishi","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.015_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archderm.142.2.213","article-title":"Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature","volume":"142","author":"Vecchietti","year":"2006","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.015_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-229596","article-title":"Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease","volume":"12","author":"Yokoyama","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"6606","key":"10.1016\/j.jaad.2022.10.015_bib14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/bmj.295.6606.1141","article-title":"Eczema after intravenous infusion of immunoglobulin","volume":"295","author":"Barucha","year":"1987","journal-title":"Br Med J Clin Res Ed"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.015_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2133.1997.tb03773.x","article-title":"Eczematous reactions to human immune globulin","volume":"137","author":"Whittam","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.10.015_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008001","article-title":"Dyshidrotic eczema associated with the use of IVIg","volume":"2013","author":"Kotan","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"11","key":"10.1016\/j.jaad.2022.10.015_bib17","doi-asserted-by":"crossref","first-page":"E530","DOI":"10.1503\/cmaj.121036","article-title":"Dyshidrotic eczema following intravenous immunoglobulin treatment","volume":"185","author":"Lee","year":"2013","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.jaad.2022.10.015_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ad.2015.09.018","article-title":"Dyshydrotic eczema secondary to intravenous immunoglobulin infusion: a report of 2 cases","volume":"107","author":"Garrido-R\u00edos","year":"2016","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"10.1016\/j.jaad.2022.10.015_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1468-3083.2008.02980.x","article-title":"Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barr\u00e9 syndrome","volume":"23","author":"Rhee","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2022.10.015_bib20","first-page":"277","article-title":"Pompholyx induced by intravenous immunoglobulin therapy","volume":"17","author":"Llombart","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2022.10.015_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/039463201402700117","article-title":"Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: a paediatric case","volume":"27","author":"Brazzelli","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.015_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archderm.142.2.247","article-title":"Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome","volume":"142","author":"Young","year":"2006","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.10.015_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14147","article-title":"Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy","volume":"33","author":"Takci","year":"2020","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.015_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.jaad.2022.10.015_bib25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamadermatol.2013.511","article-title":"Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers","volume":"149","author":"Summers","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2022.10.015_bib26","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/sj.jid.5701018","article-title":"Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study","volume":"127","author":"Joly","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2022.10.015_bib27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2022.10.015_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153740","article-title":"Safety and efficacy of methotrexate in psoriasis: A meta-analysis of published trials","volume":"11","author":"West","year":"2016","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.jaad.2022.10.015_bib29","article-title":"Long-term safety of methotrexate in the treatment of rheumatoid arthritis","volume":"28","author":"Yazici","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.10.015_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/clim.2001.5004","article-title":"The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30\/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy","volume":"99","author":"Leucht","year":"2001","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.jaad.2022.10.015_bib31","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamadermatol.2014.109","article-title":"Eczematous reaction to intravenous immunoglobulin: an alternative cause of eczema","volume":"150","author":"Miyamoto","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2022.10.015_bib32","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1212\/WNL.54.9.1879","article-title":"Pompholyx after IV immunoglobulin therapy for neurologic disease","volume":"54","author":"Ikeda","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jaad.2022.10.015_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1398-9995.2005.00937.x","article-title":"Vesicular and bullous eczema in response to intravenous immunoglobulins (IVIG)","volume":"61","author":"Maetzke","year":"2006","journal-title":"Allergy"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222028869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222028869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:09:23Z","timestamp":1759273763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222028869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0190962222028869"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.10.015","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}